| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥3301.9B | ¥3227.6B | +2.3% |
| Operating Income | ¥184.7B | ¥173.6B | +6.3% |
| Ordinary Income | ¥214.6B | ¥216.5B | -0.8% |
| Net Income | ¥145.8B | ¥-6.6B | +2319.0% |
| ROE | 4.8% | -0.2% | - |
FY2025 full-year results: Revenue 330.2B yen (YoY +2.3%), Operating Income 18.5B yen (YoY +6.3%), Ordinary Income 21.5B yen (YoY -0.8%), Net Income 14.6B yen (YoY +2319.0%). The company achieved revenue and operating profit growth driven by increased cosmetics sales and cost management improvements. The dramatic recovery in net income from prior year's loss of -0.7B yen reflects normalization from prior-year extraordinary losses combined with current-year asset disposal gains of 2.7B yen. Operating margin improved to 5.6% from 5.4% YoY, demonstrating enhanced operational efficiency. The revenue growth, while modest at 2.3%, was geographically diversified with Japan +1.9%, Asia +8.6%, and North America -0.3%. The company maintains an exceptionally strong balance sheet with equity ratio of 77.5% and cash reserves of 92.5B yen against minimal interest-bearing debt of 0.8B yen.
Revenue expanded 7.4B yen (+2.3%) to 330.2B yen, with growth concentrated in the Cosmetics segment which increased 7.0B yen to 262.3B yen (+2.7%), while the Cosmetology segment declined slightly by 0.2B yen to 64.5B yen (-0.4%). Geographically, Japan contributed 215.3B yen (+1.9%), Asia 44.1B yen (+8.6%), North America 61.8B yen (-0.3%), and other regions 8.9B yen (+1.9%). The Asia region demonstrated the strongest momentum with 3.5B yen absolute growth, indicating successful overseas market expansion. Operating profit increased 1.1B yen to 18.5B yen (+6.3%), outpacing revenue growth due to improved gross margin and controlled SG&A expenses, which rose 2.3% in line with revenue growth. The operating margin improvement of 0.2 percentage points to 5.6% reflects operating leverage benefits. Ordinary income declined modestly by 0.2B yen to 21.5B yen (-0.8%), as non-operating expenses increased, partially offsetting non-operating income including equity method investment gains and financial income totaling approximately 3.0B yen net contribution. Net income surged dramatically from -0.7B yen loss to 14.6B yen profit, a turnaround of 15.3B yen. This reflects three factors: normalization from prior-year impairment and restructuring charges, current-year extraordinary gains of 2.7B yen from fixed asset sales, and tax expense normalization. Excluding non-recurring items, underlying profitability improved moderately. The performance pattern follows revenue up/profit up, with operating leverage driving margin expansion despite modest top-line growth.
The Cosmetics segment generated revenue of 262.3B yen (+2.7% YoY) and operating income of 16.8B yen (prior year 15.1B yen, +11.4% YoY), representing the core business with 80.3% of total revenue. The segment margin improved to 6.4% from 5.9% YoY, a 0.5 percentage point enhancement, driven by product mix optimization and operational efficiency gains. The Cosmetology segment recorded revenue of 64.5B yen (-0.4% YoY) and operating income of 6.3B yen (prior year 7.0B yen, -10.4% YoY), with margin compression to 9.7% from 10.8%. The margin differential of 3.3 percentage points between segments reflects differences in product positioning and distribution channel economics, with Cosmetology maintaining higher margins despite volume challenges. The Other segment contributed 3.4B yen revenue (+26.3% YoY) and 1.7B yen operating income (prior year 1.4B yen, +18.8%), including amenity products and real estate rental businesses. Corporate costs not allocated to segments totaled 6.2B yen, primarily consisting of headquarters administrative functions and basic research expenses. The Cosmetics segment's strong profit growth demonstrates successful brand portfolio management, while the Cosmetology segment's margin pressure warrants attention for competitive dynamics and channel mix shifts.
[Profitability] ROE 5.0% improved from prior year's negative ROE due to return to profitability, though remains below the company's historical average. Operating margin 5.6% expanded 0.2 percentage points from 5.4% YoY, reflecting operational efficiency improvements. Net profit margin 4.4% represents recovery from prior-year loss but includes non-recurring gains. Gross profit margin stands at approximately 36.5% based on operating structure. [Cash Quality] Cash and equivalents 92.5B yen provide substantial liquidity buffer, with cash coverage of short-term debt at 115.7x given minimal debt of 0.8B yen. Operating cash flow of 11.1B yen represents 0.76x of net income, indicating working capital headwinds affecting cash conversion. Days sales outstanding extended to 62 days and days inventory outstanding to 155 days, suggesting working capital efficiency deterioration. [Investment Efficiency] Total asset turnover 0.84x reflects capital-intensive nature of brand-driven cosmetics business. Construction in progress reached 22.3B yen (27.2% of fixed assets), indicating significant growth investments underway requiring monitoring of deployment timeline and returns. Capital expenditure of 17.1B yen exceeded depreciation by 1.57x, confirming investment phase. [Financial Health] Equity ratio 77.5% represents exceptionally strong capitalization, improved from 75.6% YoY. Current ratio 362.2% and quick ratio 293.3% indicate ample short-term liquidity. Debt-to-equity ratio 0.003x reflects minimal leverage with interest-bearing debt of only 0.8B yen. Net cash position of 91.7B yen provides strategic flexibility. Interest coverage ratio of 419x demonstrates negligible financial risk from debt servicing.
Operating cash flow of 11.1B yen represents 0.76x of net income, below the 0.8x threshold for quality earnings, primarily due to working capital buildups including inventory increase and receivables extension. The cash conversion cycle lengthened to approximately 290 days, driven by days inventory outstanding of 155 days and days sales outstanding of 62 days, partially offset by days payables outstanding of 38 days. Despite profitability improvements, the operating cash generation remains constrained by working capital intensity. Investing cash flow outflow of 17.7B yen was primarily driven by capital expenditures of 17.1B yen for facility expansion and system investments, along with intangible asset acquisitions. Asset disposals generated proceeds of 3.7B yen, contributing to the extraordinary gains recognized in the income statement. Financing cash flow outflow of 8.0B yen reflected dividend payments and no material debt transactions given the minimal leverage position. Free cash flow of negative 6.6B yen indicates that investment activities exceeded operating cash generation, positioning the company in a growth investment phase where dividend payments rely partly on accumulated cash reserves rather than current-period free cash flow generation. The negative FCF coverage ratio of -0.78x for dividends signals the importance of working capital efficiency improvements and operating cash flow enhancement to sustain shareholder returns. Cash and deposits increased 10.9B yen YoY to 92.5B yen, providing adequate liquidity despite negative free cash flow, supported by the strong balance sheet position.
Ordinary income of 21.5B yen versus operating income of 18.5B yen shows non-operating net contribution of approximately 3.0B yen, comprising primarily equity method investment gains, interest and dividend income, and foreign exchange impacts. Non-operating income represents 0.9% of revenue, a relatively modest proportion indicating core earnings are driven primarily by operations. The gap between ordinary income and net income widened due to extraordinary gains of 2.7B yen from fixed asset disposals, which constitute approximately 18.5% of pre-tax income, representing material one-time contribution to bottom-line results. Operating cash flow of 11.1B yen relative to net income of 14.6B yen yields a ratio of 0.76x, falling short of the 0.8x benchmark for quality earnings. This shortfall stems from working capital deterioration, specifically inventory accumulation and accounts receivable extension, suggesting that reported profits are not fully converting to cash in the current period. The accrual-based earnings therefore contain lower cash backing than optimal. Excluding the non-recurring asset disposal gains of 2.7B yen, normalized net income approximates 12.6B yen, which more accurately reflects sustainable earning power. The combination of meaningful extraordinary gains and below-threshold cash conversion indicates that current-period earnings quality requires normalization adjustments and improvement in working capital management is essential to enhance cash-backed earnings sustainability.
Full-year guidance projects revenue of 350.0B yen (+6.0% YoY), operating income of 20.0B yen (+8.3% YoY), ordinary income of 21.0B yen (-2.2% YoY), and net income of 12.1B yen. Current full-year actual results show revenue of 330.2B yen representing 94.3% progress, operating income of 18.5B yen representing 92.4% progress, ordinary income of 21.5B yen representing 102.1% progress, and net income of 14.6B yen representing 120.5% progress. The operating income progress rate of 92.4% aligns reasonably with full-year expectations given typical quarterly seasonality. The ordinary income achievement of 102.1% has already exceeded guidance, while net income achievement of 120.5% substantially exceeds the forecast, reflecting stronger-than-anticipated extraordinary gains and tax effects. The guidance implies Q4 or remaining period would require approximately 19.8B yen revenue, 1.5B yen operating income, and net loss of 2.5B yen to reconcile with full-year targets. The net income guidance of 12.1B yen appears conservative given current achievement of 14.6B yen, suggesting management anticipates non-recurrence of current-year extraordinary gains or potential charges in subsequent periods. The revised revenue growth expectation of 6.0% implies acceleration from current 2.3% growth, requiring stronger performance or consolidation timing factors. The ordinary income decline guidance of -2.2% contrasts with current overachievement, indicating caution regarding non-operating income sustainability or anticipated expenses.
Annual dividend of 70 yen per share for the current fiscal year represents total planned distribution, with interim dividend of 70 yen already paid and year-end dividend of 70 yen forecasted, totaling 140 yen per share annually based on the forecast disclosure. The total dividend payment amounts to approximately 8.0B yen. The payout ratio based on net income of 14.6B yen is approximately 54.8%, which is elevated but within sustainable range given the strong balance sheet. However, the free cash flow of negative 6.6B yen results in FCF payout coverage of -1.21x, indicating dividends are being paid from accumulated cash reserves rather than current-period free cash flow generation. This reliance on balance sheet cash is temporarily sustainable given cash reserves of 92.5B yen, but underscores the importance of improving operating cash flow conversion and working capital efficiency to support ongoing distributions. No share buyback activities were disclosed. The dividend policy appears focused on stable shareholder returns despite underlying cash flow challenges, supported by ample liquidity and conservative financial position. The total return to shareholders of 8.0B yen represents 6.8% of operating cash flow (which is negative on an FCF basis), highlighting the strategic use of balance sheet strength to maintain dividends during an investment growth phase. Sustainability of the current dividend level depends on successful conversion of capital investments into improved profitability and cash generation, along with resolution of working capital inefficiencies.
Working capital deterioration with days inventory outstanding at 155 days (exceeding 90-day benchmark by 72%) and days sales outstanding at 62 days (exceeding 45-day benchmark by 38%) creates risk of inventory obsolescence, markdown pressure, and delayed cash collection. The total working capital cycle of approximately 290 days ties up significant capital and constrains operating cash flow generation, with inventory carrying value of 140.4B yen potentially exposed to fashion cycle and demand volatility risks. Construction in progress of 22.3B yen representing 27.2% of fixed assets and 84% year-over-year increase presents execution risk regarding project completion timelines, budget overruns, and ultimate return realization on these capital investments. The delayed conversion of CIP into productive revenue-generating assets could impact ROI and depress returns if deployment lags or market conditions shift. Operating cash flow to net income ratio of 0.76x falling below 0.8x threshold indicates earnings quality concern where reported profitability is not fully translating to cash generation. This pattern, if sustained, could pressure the company's ability to self-fund growth investments and maintain shareholder distributions without drawing down cash reserves, particularly given current negative free cash flow of 6.6B yen and dividend payments of 8.0B yen exceeding operating cash flow available for distribution.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating Margin 5.6% reflects moderate profitability in the cosmetics manufacturing sector, which typically exhibits margins ranging from 5-15% depending on brand positioning and channel mix. The company's margin expansion of 0.2 percentage points demonstrates operational improvement trajectory. Net profit margin of 4.4% is influenced by current-year extraordinary items and is below premium beauty brands but aligns with mid-tier mass-market cosmetics operators. Growth: Revenue growth of 2.3% is modest compared to high-growth beauty and personal care segments experiencing 5-10% annual expansion, suggesting market share pressure or mature domestic market constraints. The Asia region growth of 8.6% indicates better alignment with regional beauty market expansion trends. Financial Health: Equity ratio of 77.5% is exceptionally conservative, significantly exceeding typical industry leverage of 40-60% equity ratios, reflecting minimal financial risk tolerance. The company's net cash position and current ratio of 362.2% far exceed industry norms where 150-200% is standard, indicating underutilized financial capacity. Efficiency: Asset turnover of 0.84x is typical for brand-driven cosmetics businesses with significant fixed asset and inventory investments. The extended inventory days of 155 and receivables days of 62 suggest working capital efficiency below best-practice operators who achieve 90-day inventory and 45-day receivables cycles. The company's historical trend shows operating margin improvement from prior periods, but revenue growth deceleration and working capital cycle extension indicate efficiency challenges relative to more agile competitors. Overall positioning suggests a financially conservative, moderate-growth operator with operational efficiency improvement opportunities.
Revenue and operating profit demonstrate resilience with 2.3% and 6.3% growth respectively, driven by operational leverage and Cosmetics segment strength, though growth pace trails high-performing beauty sector peers. The operating margin expansion to 5.6% and segment profit growth in core Cosmetics business (+11.4%) indicate improving business quality, but sustainability depends on resolving working capital inefficiencies. Net income recovery from prior-year loss to 14.6B yen profit is materially influenced by non-recurring asset disposal gains of 2.7B yen (18.5% of pre-tax income), requiring normalization to assess underlying earning power of approximately 12.6B yen. Operating cash flow conversion ratio of 0.76x and negative free cash flow of 6.6B yen highlight working capital management as critical concern, with inventory days of 155 and receivables days of 62 both exceeding benchmarks and constraining cash generation despite improving profitability. Shareholder returns of 8.0B yen annual dividends are supported by exceptionally strong balance sheet (equity ratio 77.5%, net cash 91.7B yen) but exceed current free cash flow generation, making operating cash flow improvement essential for sustainable distribution policy. Construction in progress buildup of 22.3B yen (up 84% YoY) represents significant growth investment requiring monitoring of deployment timeline and return realization, with capital expenditure of 1.57x depreciation confirming investment phase that should yield future revenue acceleration if executed successfully.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.